Laddar...
What is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatment
Polycystic ovary syndrome, the most common gynecological endocrinopathy, is burdened with a state of hyperinsulinemia and insulin resistance in 50–80% of affected women. Wherever the origin of these metabolic abnormalities lies, their pathogenetic role in determining, perpetuating, and worsening the...
Sparad:
| I publikationen: | Ther Adv Reprod Health |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publications
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7236839/ https://ncbi.nlm.nih.gov/pubmed/32435760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2633494120908709 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|